Achieving widespread vaccine access worldwide requires more than scientific breakthroughs—it takes smart strategies to motivate development, production, and distribution. Two powerful approaches used to accelerate global immunization are push and pull incentives. When combined, they can transform how life-saving vaccines reach people everywhere.
What Are Push Incentives?
Push incentives provide funding and resources early in the research and development process to reduce the upfront cost and risk for innovators.
These can include grants, research subsidies, tax credits, or technical support for clinical trials. By lowering the financial barrier, push incentives encourage companies, universities, and labs to work on vaccines that might otherwise be seen as too risky or unprofitable.
Example: A government might fund early-stage research on a vaccine for a rare disease, helping scientists gather the data needed to move toward trials.
What Are Pull Incentives?
Pull incentives create rewards or guaranteed markets for successful vaccines after they are developed.
These include purchase commitments, market guarantees, or prizes for meeting specific health goals. Pull incentives motivate manufacturers to scale production and deliver vaccines efficiently because they know there will be demand and a financial return.
Example: A coalition of countries might commit to buying a certain number of doses once a vaccine meets safety and efficacy standards, ensuring companies have a secure market.
Why Both Are Needed
Push incentives spark innovation, while pull incentives ensure that innovation translates into real-world access.
Without push funding, promising ideas might never leave the lab. Without pull commitments, companies might not invest in manufacturing or distribution. When used together, these incentives create a complete pathway—from research to delivery—that accelerates vaccine availability.
Impact on Global Immunization
Push and pull incentives have helped develop and distribute vaccines for diseases like pneumococcal infections, Ebola, and COVID-19.
They are especially valuable for vaccines targeting low-income countries, where profit margins are low and commercial interest may be limited. By reducing risk and guaranteeing demand, these incentives align public health goals with private sector capabilities.
Building a Healthier Future
Expanding the use of push and pull incentives could speed up the fight against existing and emerging diseases.
When governments, nonprofits, and the private sector collaborate on these strategies, they can drive innovation, ensure equitable access, and protect vulnerable populations—saving millions of lives in the process.